Henan Taloph Pharmaceutical Stock Co.,Ltd. Posted 75.7 Million Yuan Net Loss in 2022

Henan Taloph Pharmaceutical Stock Co.,Ltd. (河南太龙药业股份有限公司) (600222.SH) reported a net loss of 75.7 million yuan in 2022, reversing a net profit of 6.8 million yuan for the previous year.

Meanwhile, the company posted 2 billion yuan in revenue, up 22.2% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 2 billion yuan in total liabilities, with a liability-to-asset ratio of 55.2%.